» » Urgent Requirement of Large Clinical Trials to Evaluate Risks of Testosterone Treatment: Lancet Diabetes (and) Endocrinology

Urgent Requirement of Large Clinical Trials to Evaluate Risks of Testosterone Treatment: Lancet Diabetes (and) Endocrinology

Insufficient information from clinical trials to understand the risks associated with the prescription of testosterone in older men, is available with physicians, suggests a Comment in iThe Lancet Diabetes (and) Endocrinology/i, written by Professor Stephanie Page, of the University of Washington and Harborview Medical Center, Seattle, USA. While the benefits of testosterone therapy in younger men with a deficiency of the hormone are well established, testosterone ...

Read More
You have just read an article categorized health titled Urgent Requirement of Large Clinical Trials to Evaluate Risks of Testosterone Treatment: Lancet Diabetes (and) Endocrinology.
Written by: editor - Sunday, April 27, 2014

There are currently no comments for "Urgent Requirement of Large Clinical Trials to Evaluate Risks of Testosterone Treatment: Lancet Diabetes (and) Endocrinology"

Post a Comment

Subscribe to: Post Comments (Atom)